Delcath Systems Inc Drug Patent Portfolio
Delcath Systems Inc's Family Patents
Clinical Trials
Recent Clinical Trials by Delcath Systems Inc:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease | Delcath Systems Inc. | NA |
RECRUITING
(May 1, 2026)
| PHASE2 |
| Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease | Delcath Systems Inc. | NA |
RECRUITING
(May 1, 2026)
| PHASE2 |
| Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma | Delcath Systems Inc. | NA |
COMPLETED
(Apr 1, 2026)
| PHASE3 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List